Physician profile
Timothy Rushmer
NPI 1952895179
$9,451.31
in general payments reported to CMS, 2019-2025
12 companies · $665 in 2025
The $665 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,087 · 2023: $5,009 · 2024: $2,691 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,725 · Travel and Lodging: $2,085 · Education: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,724.66 |
| Travel and Lodging | $2,085.47 |
| Education | $554.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,909.31 | 2023-2025 | Intellis Adaptivestim, Restoresensorsurescan, Vanta Adaptivestim |
| Boston Scientific Corporation | $1,447.97 | 2022-2025 | Wavewriter Alpha Prime 16, Infinion 16, Infinion 16 |
| Abbott Laboratories | $1,172.28 | 2022-2025 | Proclaim, Ionicrf, Octrode |
| Painteq LLC | $554.58 | 2023-2024 | Painteq |
| Relievant Medsystems, INC. | $523.79 | 2023 | Intracept |
| Nevro Corp. | $514.84 | 2022-2024 | Senza |
| Nalu Medical, INC. | $458.47 | 2024-2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $331.53 | 2022-2023 | Sprint Pns System |
| Si-Bone, INC. | $283.13 | 2024-2025 | |
| Curonix LLC | $205.93 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinefrontier, INC. | $29.00 | 2023 | Sacrix, Nanofuse, Inspan |
| Vericel Corporation | $20.48 | 2024 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Rushmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.